A Clinical Trial to Evaluate the Safety and Efficacy of ADX-629 in in Subjects With Elevated Ethanol Levels

Clinical trial NCT05487404 · COMPLETED

Trial details

NCT number: NCT05487404
Sponsor: Aldeyra Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ethanol Intoxication

Start date: 2021-11-15
Primary completion: 2022-05-29
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.